Dhananjay Patankar

Dr. Dhananjay Patankar is an independent biopharmaceutical professional and has been intimately involved in the growth of the Indian biopharmaceutical industry since its early days.

Over his career, he led teams that developed India’s first biosimilar therapeutic product, India’s first biosimilar approved for marketing in Europe, India’s first EU-GMP certified biologics manufacturing facility, and India’s first commercial contract manufacturing of a novel biologic for the US market.  He has served in various national committees and biotechnology industry bodies in India, and was Biologics Expert Committee member at the US Pharmacopeia from 2011 till 2020.

By education he is a Chemical Engineer with bachelor’s degree from IIT Mumbai and Ph.D. from University of Utah in the US.